{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:43:58Z","timestamp":1790297038884,"version":"4.1.0"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,9,21]]},"DOI":"10.1093\/jnci\/dji277","type":"journal-article","created":{"date-parts":[[2005,9,20]],"date-time":"2005-09-20T16:47:58Z","timestamp":1127234878000},"page":"1345-1353","source":"Crossref","is-referenced-by-count":163,"title":["Long-Term Results of Anti\u2013 Helicobacter pylori Therapy in Early-Stage Gastric High-Grade Transformed MALT Lymphoma"],"prefix":"10.1093","volume":"97","author":[{"given":"Li-Tzong","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaw-Town","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Jen","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gran-Hum","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Zen","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Shun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiu-Po","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Hsin","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bor-Shyang","family":"Sheu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Ming","family":"Jan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Ming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsang-En","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chew-Wun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Long","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ih-Jen","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Whang-Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Lii","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,9,21]]},"reference":[{"key":"key\n\t\t\t\t20171012234828_BIB1","doi-asserted-by":"crossref","unstructured":"Isaacson PG, Wright DH. Malignant lymphoma of mucosa-associated lymphoid tissue. A distinct type of B-cell lymphoma. Cancer1983 ; 82 : 1410 \u20136.","DOI":"10.1002\/1097-0142(19831015)52:8<1410::AID-CNCR2820520813>3.0.CO;2-3"},{"key":"key\n\t\t\t\t20171012234828_BIB2","doi-asserted-by":"crossref","unstructured":"A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma: the non-Hodgkin's Lymphoma Classification Project. Blood1997 ; 89 : 3909 \u201318.","DOI":"10.1182\/blood.V89.11.3909"},{"key":"key\n\t\t\t\t20171012234828_BIB3","doi-asserted-by":"crossref","unstructured":"Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG. Helicobacter pylori associated gastritis and primary B-cell gastric lymphoma. Lancet1991 ; 338 : 1175 \u20136.","DOI":"10.1016\/0140-6736(91)92035-Z"},{"key":"key\n\t\t\t\t20171012234828_BIB4","doi-asserted-by":"crossref","unstructured":"Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni M, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet1993 ; 342 : 575 \u20137.","DOI":"10.1016\/0140-6736(93)91409-F"},{"key":"key\n\t\t\t\t20171012234828_BIB5","doi-asserted-by":"crossref","unstructured":"Roggero E, Zucca E, Pinotti G, Pascarella A, Capella C, Savio A, et al. Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue. Ann Intern Med1995 ; 122 : 767 \u20139.","DOI":"10.7326\/0003-4819-122-10-199505150-00006"},{"key":"key\n\t\t\t\t20171012234828_BIB6","doi-asserted-by":"crossref","unstructured":"Neubauer A, Thiede C, Morgner A, Alpen B, Ritter M, Neubauer B, et al. Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma. J Natl Cancer Inst1997 ; 89 : 1350 \u20135.","DOI":"10.1093\/jnci\/89.18.1350"},{"key":"key\n\t\t\t\t20171012234828_BIB7","unstructured":"Montalban C, Santon A, Boixeda D, Redondo C, Alvarez I, Calleja JL, et al. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up. Haematologica2001 ; 86 : 609 \u201317."},{"key":"key\n\t\t\t\t20171012234828_BIB8","doi-asserted-by":"crossref","unstructured":"Steinbach G, Ford R, Glober G, Sample D, Hagemeister FB, Lynch PM, et al. Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue: an uncontrolled study. Ann Intern Med1999 ; 131 : 88 \u201395.","DOI":"10.7326\/0003-4819-131-2-199907200-00003"},{"key":"key\n\t\t\t\t20171012234828_BIB9","doi-asserted-by":"crossref","unstructured":"Weston AP, Banerjee SK, Horvat RT, Zoubine MN, Campbell DR, Cherian R. Prospective long-term endoscopic and histologic follow-up of gastric lymphoproliferative disease of early stage IE low-grade B-cell mucosa-associated lymphoid tissue type following Helicobacter pylori eradication treatment. Int J Oncol1999 ; 15 : 899 \u2013907.","DOI":"10.3892\/ijo.15.5.899"},{"key":"key\n\t\t\t\t20171012234828_BIB10","unstructured":"Begum S, Sano T, Endo H, Kawamata H, Urakami Y. Mucosal changes of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori : follow-up study of 48 cases. J Med Invest2000 ; 47 : 36 \u201346."},{"key":"key\n\t\t\t\t20171012234828_BIB11","doi-asserted-by":"crossref","unstructured":"Ruskone-Fourmestaux A, Lavergne A, Aegerter PH, Megraud F, Palazzo L, de Mascarel A, et al. Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment. Gut2001 ; 48 : 297 \u2013303.","DOI":"10.1136\/gut.48.3.297"},{"key":"key\n\t\t\t\t20171012234828_BIB12","doi-asserted-by":"crossref","unstructured":"Fischbach W, Goebeler-Kolve ME, Dragosics B, Greiner A, Stolte M. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series. Gut2004 ; 53 : 34 \u20137.","DOI":"10.1136\/gut.53.1.34"},{"key":"key\n\t\t\t\t20171012234828_BIB13","doi-asserted-by":"crossref","unstructured":"Kim YS, Kim JS, Jung HC, Lee CH, Kim CW, Song IS, et al. Regression of low-grade gastric mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: possible association with p16 hypermethylation. J Gastroenterol2002 ; 37 : 17 \u201322.","DOI":"10.1007\/s535-002-8127-8"},{"key":"key\n\t\t\t\t20171012234828_BIB14","unstructured":"Chiang IP, Wang HH, Cheng AL, Lin JT, Su IJ. Low-grade gastric B-cell lymphoma of mucosa-associated lymphoid tissue: clinicopathologic analysis of 19 cases. J Formos Med Assoc1996 ; 95 : 857 \u201365."},{"key":"key\n\t\t\t\t20171012234828_BIB15","doi-asserted-by":"crossref","unstructured":"Hussell T, Isaacson PG, Crabtree JE, Spencer J. The response of cells from low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet1993 ; 342 : 571 \u20134.","DOI":"10.1016\/0140-6736(93)91408-E"},{"key":"key\n\t\t\t\t20171012234828_BIB16","doi-asserted-by":"crossref","unstructured":"Seymour JF, Anderson R, Bhathal PS. Regression of gastric lymphoma with therapy for Helicobacter pylori infection. Ann Intern Med1997 ; 127 : 247 .","DOI":"10.7326\/0003-4819-127-3-199708010-00026"},{"key":"key\n\t\t\t\t20171012234828_BIB17","doi-asserted-by":"crossref","unstructured":"Ng WW, Lam CP, Chau WK, Li FY, Huang CC, Chang FY, et al. Regression of high-grade gastric mucosa-associated lymphoid tissue lymphoma with Helicobacter pylori after triple antibiotic therapy. Gastrointest Endosc2000 ; 51 : 93 \u20136.","DOI":"10.1016\/S0016-5107(00)70399-3"},{"key":"key\n\t\t\t\t20171012234828_BIB18","doi-asserted-by":"crossref","unstructured":"Alpen B, Robbecke J, Wundisch T, Stolte M, Neubauer A. Helicobacter pylori eradication therapy in gastric high grade non Hodgkin's lymphoma (NHL). Ann Hematol2001 ; 80 Suppl 3: B106 \u20137.","DOI":"10.1007\/PL00022770"},{"key":"key\n\t\t\t\t20171012234828_BIB19","doi-asserted-by":"crossref","unstructured":"Salam I, Durai D, Murphy JK, Sundaram B. Regression of primary high-grade gastric B-cell lymphoma following Helicobacter pylori eradication. Eur J Gastroenterol Hepatol2001 ; 13 : 1375 \u20138.","DOI":"10.1097\/00042737-200111000-00018"},{"key":"key\n\t\t\t\t20171012234828_BIB20","doi-asserted-by":"crossref","unstructured":"Miki H, Hideo S, Harada H, Yamanoi Y, Uraoka T, Sotozono M, et al. Early stage gastric MALT lymphoma with high-grade component cured by Helicobacter pylori eradication. J Gastroenterol2001 ; 36 : 121 \u20134.","DOI":"10.1007\/s005350170140"},{"key":"key\n\t\t\t\t20171012234828_BIB21","doi-asserted-by":"crossref","unstructured":"Morgner A, Miehlke S, Fischbach W, Schmitt W, Muller-Hermelink H, Greiner A, et al. Complete remission of primary high-grade B-cell gastric lymphoma after cure of Helicobacter pylori infection. J Clin Oncol2001 ; 19 : 2041 \u20138.","DOI":"10.1200\/JCO.2001.19.7.2041"},{"key":"key\n\t\t\t\t20171012234828_BIB22","doi-asserted-by":"crossref","unstructured":"Montalban C, Santon A, Boixeda D, Bellas C. Regression of gastric high-grade mucosa associated lymphoid tissue (MALT) lymphoma after Helicobacter pylori eradication. Gut2001 ; 49 : 584 \u20137.","DOI":"10.1136\/gut.49.4.584"},{"key":"key\n\t\t\t\t20171012234828_BIB23","doi-asserted-by":"crossref","unstructured":"Sugimoto M, Kajimura M, Sato Y, Hanai H, Kaneko E, Kobayashi H. Regression of primary gastric diffuse large B-cell lymphoma after eradication of Helicobacter pylori. Gastrointest Endosc2001 ; 54 : 643 \u20135.","DOI":"10.1067\/mge.2001.118647"},{"key":"key\n\t\t\t\t20171012234828_BIB24","doi-asserted-by":"crossref","unstructured":"Gretschel S, Hunerbein M, Foss HD, Krause M, Schlag PM. Regression of high-grade gastric B-cell lymphoma after eradication of Helicobacter pylori. Endoscopy2001 ; 33 : 805 \u20137.","DOI":"10.1055\/s-2001-16527"},{"key":"key\n\t\t\t\t20171012234828_BIB25","doi-asserted-by":"crossref","unstructured":"Hiyama T, Haruma K, Kitadai Y, Ito M, Masuda H, Miyamoto M, et al. Helicobacter pylori eradication therapy for high-grade mucosa-associated lymphoid tissue lymphomas of the stomach with analysis of p53 and K-ras alteration and microsatellite instability. Int J Oncol2001 ; 18 : 1207 \u201312.","DOI":"10.3892\/ijo.18.6.1207"},{"key":"key\n\t\t\t\t20171012234828_BIB26","doi-asserted-by":"crossref","unstructured":"Alsolaiman MM, Bakis G, Nazeer T, MacDermott RP, Balint JA. Five years of complete remission of gastric diffuse large B cell lymphoma after eradication of Helicobacter pylori infection. Gut2003 ; 52 : 507 \u20139.","DOI":"10.1136\/gut.52.4.507"},{"key":"key\n\t\t\t\t20171012234828_BIB27","doi-asserted-by":"crossref","unstructured":"Chen LT, Lin JT, Shyu RY, Jan CM, Chen CL, Chiang IP, et al. Prospective study of Helicobacter pylori eradication therapy in stage IE high-grade mucosa-associated lymphoid tissue lymphoma of the stomach. J Clin Oncol2001 ; 19 : 4245 \u201351.","DOI":"10.1200\/JCO.2001.19.22.4245"},{"key":"key\n\t\t\t\t20171012234828_BIB28","doi-asserted-by":"crossref","unstructured":"Nakamura S, Matumoto T, Suekane H, Takeshita M, Hizawa K, Kawasaki M, et al. Predictive value of endoscopic ultrasonography for regression of gastric low-grade and high-grade MALT lymphomas after eradication of Helicobacter pylori. Gut2001 ; 48 : 454 \u201360.","DOI":"10.1136\/gut.48.4.454"},{"key":"key\n\t\t\t\t20171012234828_BIB29","doi-asserted-by":"crossref","unstructured":"Harris NL, Jaffe ES, Diebold J, Fladrin G, Muller-Hermelink HK, Vardiman J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the clinical advisory committee meeting\u2014Airlie House, Virginia, November 1997. J Clin Oncol1999 ; 17 : 3835 \u201349.","DOI":"10.1200\/JCO.1999.17.12.3835"},{"key":"key\n\t\t\t\t20171012234828_BIB30","doi-asserted-by":"crossref","unstructured":"Ely S. Distinction between \u201chigh grade MALT\u201d and diffuse large B cell lymphoma of mucosa associated lymphoid tissue. Gut2002 ; 51 : 893 .","DOI":"10.1136\/gut.51.6.893"},{"key":"key\n\t\t\t\t20171012234828_BIB31","doi-asserted-by":"crossref","unstructured":"Kahl BS. Update: gastric MALT lymphoma. Curr Opin Oncol2003 ; 15 : 347 \u201352.","DOI":"10.1097\/00001622-200309000-00001"},{"key":"key\n\t\t\t\t20171012234828_BIB32","doi-asserted-by":"crossref","unstructured":"Isaacson PG, Spencer J. Malignant lymphoma of mucosa-associated lymphoid tissue. Histopathology1987 ; 11 : 445 \u201362.","DOI":"10.1111\/j.1365-2559.1987.tb02654.x"},{"key":"key\n\t\t\t\t20171012234828_BIB33","unstructured":"Chan JK, Ng CS, Isaacson PG. Relationship between high-grade lymphoma and low-grade B-cell lymphoma of mucosa-associated lymphoid tissue (MALToma) of the stomach. Am J Pathol1990 ; 136 : 1153 \u201364."},{"key":"key\n\t\t\t\t20171012234828_BIB34","doi-asserted-by":"crossref","unstructured":"de Jong D, Aleman BM, Taal BG, Boot H. Controversies and consensus in the diagnosis, work-up and treatment of gastric lymphoma: an international survey. Ann Oncol1999 ; 10 : 275 \u201380.","DOI":"10.1023\/A:1008392022152"},{"key":"key\n\t\t\t\t20171012234828_BIB35","unstructured":"Musshoff K. Klinische Stadieneinteilung der nicht-Hodgkin Lymphome. Strahlenthreapie Onkol1977 ; 153 : 218 \u201321."},{"key":"key\n\t\t\t\t20171012234828_BIB36","doi-asserted-by":"crossref","unstructured":"Kaplan ER, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc1958 ; 53 : 457 \u201381.","DOI":"10.1080\/01621459.1958.10501452"},{"key":"key\n\t\t\t\t20171012234828_BIB37","doi-asserted-by":"crossref","unstructured":"Nakamura T, Inagaki H, Seto M, Nakamura S. Gastric low-grade B-cell MALT lymphoma: treatment, response, and genetic alteration. J Gastroenterol2003 ; 38 : 921 \u20139.","DOI":"10.1007\/s00535-003-1234-4"},{"key":"key\n\t\t\t\t20171012234828_BIB38","doi-asserted-by":"crossref","unstructured":"Ye H, Liu H, Raderer M, Chott A, Ruskone-Fourmestraux A, Wotherspoon A, et al. High incidence of t(11;18) (q21;q21) in Helicobacter pylori-negative gastric MALT lymphoma. Blood2003 ; 101 : 2547 \u201350.","DOI":"10.1182\/blood-2002-10-3167"},{"key":"key\n\t\t\t\t20171012234828_BIB39","doi-asserted-by":"crossref","unstructured":"Rosenwald A, Ott G, Stilgenbauer S, Kalla J, Bredt M, Katzenberger T, et al. Exclusive deletion of the t(11;18) (q21;q21) in extranodal marginal zone B cell lymphomas (MZBL) of MALT type in contrast to other MZBL and extranodal large B cell lymphomas. Am J Pathol1999 ; 155 : 1817 \u201321.","DOI":"10.1016\/S0002-9440(10)65499-5"},{"key":"key\n\t\t\t\t20171012234828_BIB40","doi-asserted-by":"crossref","unstructured":"Willis TG, Jadayel DM, Du MQ, Peng H, Perry AR, Abdul-Rauf M, et al. Bcl10 is involved in t(1;14) (p22; q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell1999 ; 96 : 35 \u201345.","DOI":"10.1016\/S0092-8674(00)80957-5"},{"key":"key\n\t\t\t\t20171012234828_BIB41","doi-asserted-by":"crossref","unstructured":"Maes B, Demunter A, Peeters B, De Wolf-Peeters C. BCL10 mutation does not represent an important pathogenic mechanism in gastric MALT-type lymphoma, and the presence of the API2-MLT fusion is associated with aberrant nuclear BCL10 expression. Blood2002 ; 99 : 1398 \u2013404.","DOI":"10.1182\/blood.V99.4.1398"},{"key":"key\n\t\t\t\t20171012234828_BIB42","doi-asserted-by":"crossref","unstructured":"Lucas PC, Yonezumi M, Inohara N, McAllister-Lucas LM, Abazeed ME, Chen FF, et al. Bcl10 and MALT1, Independent targets of chromosomal translocation in MALT Lymphoma, cooperate in a novel NF-\u03baB signaling pathway. J Biol Chem2001 ; 276 : 19012 \u20139.","DOI":"10.1074\/jbc.M009984200"},{"key":"key\n\t\t\t\t20171012234828_BIB43","doi-asserted-by":"crossref","unstructured":"Alpen B, Neubauer A, Dierlamm J, Marynen P, Thiede C, Bayerdorfer E, et al. Translocation t(1;18) absent in early gastric marginal zone B-cell lymphoma of MALT type responding to eradication of Helicobacter pylori infection. Blood2000 ; 95 : 4014 \u20135.","DOI":"10.1182\/blood.V95.12.4014"},{"key":"key\n\t\t\t\t20171012234828_BIB44","doi-asserted-by":"crossref","unstructured":"Liu H, Ye H, Ruskone-Fourmestraux A, De Jong D, Pileri S, Thiede C, et al. T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology2002 ; 122 : 1286 \u201394.","DOI":"10.1053\/gast.2002.33047"},{"key":"key\n\t\t\t\t20171012234828_BIB45","doi-asserted-by":"crossref","unstructured":"Baens M, Maes B, Steyls A, Geboes K, Marynen P, De Wolf-Peeters C. The product of the t(11;18), an API2-MLT fusion, marks nearly half of gastric MALT type lymphomas without large cell proliferation. Am J Pathol2000 ; 156 : 1433 \u20139.","DOI":"10.1016\/S0002-9440(10)65012-2"},{"key":"key\n\t\t\t\t20171012234828_BIB46","doi-asserted-by":"crossref","unstructured":"Kuo SH, Chen LT, Yeh KH, Wu MS, Hsu HC, Yeh PY, et al. Nuclear expression of BCL10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of early-stage, high-grade gastric mucosa-associated lymphoid tissue lymphomas. J Clin Oncol2004 ; 22 : 3491 \u20137.","DOI":"10.1200\/JCO.2004.10.087"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/97\/18\/1345\/7686593\/dji277.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T13:13:32Z","timestamp":1683206012000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jnci\/article\/97\/18\/1345\/2521386\/LongTerm-Results-of-Anti-Helicobacter-pylori"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9,21]]},"references-count":46,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2005,9,21]]},"published-print":{"date-parts":[[2005,9,21]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/dji277","relation":{},"ISSN":["1460-2105","0027-8874"],"issn-type":[{"value":"1460-2105","type":"electronic"},{"value":"0027-8874","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,9,21]]},"published":{"date-parts":[[2005,9,21]]}}}